Qu Biologics

Developing Site Specific Immunomodulators that aim to reboot the body's immune system to treat cancer and immune-related diseases, such as Crohn's

placeVancouver, British Columbia, Canada calendar_todayFounded 2007 groups22 employees language qubiologics.com

Innovation

15 patent families (7 granted) — focus: Human necessities, Physics & computing, Emerging technologies; filing pace steady. Cited 2,689 times.

YearFilings
20132
20151
20164
20176
20185
20196
20207
20214
20223
20234
20244
20255

Social engagement

Social engagement: 4.6K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital250%
Private equity125%
Other / undisclosed125%

Recent activity

24 Jun 2026
Event
BIO International Convention 2026
19 Jun 2026
Event
BIO International Convention 2026
19 May 2026
Event
BIO International Convention
Coming soon